X4 Pharmaceuticals (XFOR) Enterprise Value Growth (1y) (2018 - 2025)
X4 Pharmaceuticals (XFOR) Enterprise Value Growth (1y) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
X4 Pharmaceuticals |
166.63 Mn |
166.63 Mn |
2.20 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
-289.68% |
| Sep 30, 2025 |
28.52% |
| Jun 30, 2025 |
73.36% |
| Mar 31, 2025 |
33.45% |
| Dec 31, 2024 |
43.86% |
| Sep 30, 2024 |
25.97% |
| Jun 30, 2024 |
-7.91% |
| Mar 31, 2024 |
35.24% |
| Dec 31, 2023 |
18.49% |
| Sep 30, 2023 |
-64.77% |
| Jun 30, 2023 |
-187.96% |
| Mar 31, 2023 |
-40.61% |
| Dec 31, 2022 |
-48.82% |
| Sep 30, 2022 |
-4.53% |
| Jun 30, 2022 |
50.23% |
| Mar 31, 2022 |
42.21% |
| Dec 31, 2021 |
-3.91% |
| Sep 30, 2021 |
13.98% |
| Jun 30, 2021 |
8.24% |
| Mar 31, 2021 |
0.09% |
